Centric Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Centric Wealth Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-4,089	Closed	-$206K	–	177
2024 Q2	$206K	Buy	+4,089	New	+$183K	0.06%	155
2021 Q2	–	Sell	-48,458	Closed	-$3.06M	–	160
2021 Q1	$3.06M	Buy	48,458 +42,334	+691%	+$2.63M	0.87%	19
2020 Q4	$380K	Buy	6,124 +682	+13%	+$41.9K	0.12%	143
2020 Q3	$268K	Sell	5,442 -355	-6%	-$21.4K	0.2%	86
2020 Q2	$341K	Buy	5,797 +355	+7%	+$21.2K	0.18%	97
2020 Q1	$268K	Sell	5,442 -107	-2%	-$6.54K	0.2%	86
2019 Q4	$356K	Buy	5,549 +107	+2%	+$6.13K	0.28%	66
2019 Q3	$268K	Buy	+5,442	New	+$256K	0.2%	86

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Centric Wealth Management's BMY Position: Q3 2024 in Review

Centric Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q3 2024, closing a stake of 4,089 shares — an estimated $206K sold.

Centric Wealth Management first reported a position in BMY in Q3 2019 and held it in 8 quarters. The position peaked at $3.06M in Q1 2021. 2,263 funds tracked by Wall St. Rank hold BMY as of Q3 2024.

Centric Wealth Management reported no remaining Bristol-Myers Squibb position as of Q3 2024 after selling out during the quarter.
Centric Wealth Management sold 4,089 Bristol-Myers Squibb shares in Q3 2024, an estimated $206K.
Centric Wealth Management first reported a position in Bristol-Myers Squibb in Q3 2019 and held it in 8 quarters.
Centric Wealth Management's Bristol-Myers Squibb position peaked at $3.06M in Q1 2021.
2,263 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2024.

Based on Centric Wealth Management's 13F filing for Q3 2024, filed 14 Nov 2024.